Sanchez T et al. |
Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17431187
|
Keul P et al. |
The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17158351
|
Auge N et al. |
Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. |
2002 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:12482824
|
Brinck JW et al. |
Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection. |
2016 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:26966278
|
Grabski AD et al. |
Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19608972
|
Rikitake Y et al. |
Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. |
2002 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:11788469
|
Murohara T |
Printing a tissue: a new engineering strategy for cardiovascular regeneration. |
2010 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:20554948
|
Hao J et al. |
The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation. |
2014 |
Arthritis Res. Ther. |
pmid:25000985
|
Kamradt T and Frey O |
Arthritis: where are the T cells? |
2010 |
Arthritis Res. Ther. |
pmid:20537200
|
Stradner MH et al. |
Sphingosine 1-phosphate counteracts the effects of interleukin-1β in human chondrocytes. |
2013 |
Arthritis Rheum. |
pmid:23666803
|
Kitano M et al. |
Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. |
2006 |
Arthritis Rheum. |
pmid:16508938
|
Callihan P et al. |
Convergent regulation of neuronal differentiation and Erk and Akt kinases in human neural progenitor cells by lysophosphatidic acid, sphingosine 1-phosphate, and LIF: specific roles for the LPA1 receptor. |
2014 |
ASN Neuro |
pmid:25424429
|
Togame H et al. |
Development of a simple and robust assay to screen for inhibitors of sphingosine kinases. |
2007 |
Assay Drug Dev Technol |
pmid:17477830
|
Tamama K et al. |
High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component. |
2005 |
Atherosclerosis |
pmid:15585196
|
Zhang B et al. |
Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins. |
2005 |
Atherosclerosis |
pmid:15585219
|
Matsuo Y et al. |
Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. |
2007 |
Atherosclerosis |
pmid:17118370
|
Kurano M et al. |
Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M. |
2013 |
Atherosclerosis |
pmid:23664237
|
Sutter I et al. |
Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL. |
2015 |
Atherosclerosis |
pmid:26093887
|
Karuna R et al. |
Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. |
2011 |
Atherosclerosis |
pmid:21944699
|
Denimal D et al. |
Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration. |
2015 |
Atherosclerosis |
pmid:26142685
|